Market Outlook

By 2035, the U.S. Computer-Assisted Surgical Systems Market is expected to reach approximately USD 38.86 billion, expanding at a CAGR of 13.62% during the forecast period 2026–2035. The market is estimated at USD 10.84 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The market expanded from an estimated USD 5.95 billion in 2021 to USD 9.39 billion in 2024, reflecting the normalization of elective surgical volumes after the pandemic, accelerated deployment of robotic-assisted surgery, rising orthopedic and spine navigation utilization, broader adoption of image-guided surgery, and growing investment in digitally connected operating rooms. Growth remained particularly strong during 2024 and 2025 as U.S. hospitals increased robotic capacity and newer systems entered soft-tissue, orthopedic, spine, neurosurgical, endovascular, and outpatient workflows.

Computer-assisted surgical systems represent a considerably broader opportunity than conventional surgical robots alone. The market includes robotic surgical platforms, computer-guided navigation systems, surgical planning software, intraoperative imaging integration, augmented-reality guidance, instrument-tracking technologies, artificial intelligence-enabled surgical analytics, platform-linked instruments and accessories, and related service infrastructure. This combined technology stack is becoming an increasingly important component of operating-room capital strategy.

The addressable clinical base is substantial. Approximately 2.01 million da Vinci procedures were performed in the United States during 2025, including about 1.25 million general surgery procedures, 468,000 gynecologic procedures and 201,000 urologic procedures. At the end of 2025, approximately 6,364 da Vinci systems were installed in the U.S., demonstrating that computer-assisted surgery has progressed beyond early adoption and is becoming an established procedural infrastructure category.

The next decade will nevertheless differ materially from the previous one. Growth through 2035 will not depend solely on additional premium robotic installations. Hospitals are moving toward multi-platform strategies, usage-based acquisition, compact robotics, intelligent navigation, patient-specific surgical planning, artificial intelligence, augmented reality, procedural video analytics, and technologies that integrate directly with implants, energy systems and operating-room workflow.

Competitive pressure will therefore increasingly shift from mechanical capability toward procedure economics, utilization, interoperability, clinical evidence, surgeon experience, data intelligence and total cost of ownership. Computer-assisted platforms capable of increasing operating-room throughput, shortening learning curves, reducing unnecessary variability, expanding minimally invasive eligibility or supporting outpatient migration are expected to command the strongest strategic interest.

 

Introduction

According to the U.S. Computer-Assisted Surgical Systems Market Report, the industry is entering an important transition from stand-alone surgical capital equipment toward integrated digital procedure ecosystems. Computer assistance can now influence almost every stage of a surgical episode, including preoperative imaging and planning, patient positioning, anatomical registration, incision strategy, instrument trajectory, robotic manipulation, implant positioning, intraoperative visualization, workflow documentation and post-procedure performance analysis.

The U.S. represents an especially attractive market because of its combination of sophisticated surgical infrastructure, high healthcare expenditure, large procedure volumes, specialist concentration, strong medical-device innovation and significant hospital investment in minimally invasive care. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds and over 35.6 million annual hospital admissions, creating an extensive installed infrastructure through which advanced surgical technologies can scale.

The ambulatory environment is becoming increasingly important as well. Medicare data show more than 6,300 ambulatory surgical centers, while current Medicare outpatient and ASC payment policies affect approximately 4,000 hospital outpatient facilities and about 6,000 ASCs. Although complex oncology, cardiac and neurosurgical procedures remain concentrated in hospitals, selected orthopedic, gynecologic, urologic and general surgical procedures are progressively moving into lower-cost outpatient environments.

This shift has strategic implications for product design. Traditional large-footprint robotic platforms were primarily optimized for tertiary hospitals capable of supporting high capital costs, dedicated operating rooms and substantial procedure throughput. Emerging systems increasingly emphasize smaller footprints, modular robotic arms, portability, simplified setup, lower infrastructure requirements and business models aligned with procedure volumes. These attributes can substantially expand the addressable market across community hospitals and ASCs.

Hospital procurement economics remain central to market development. Computer-assisted surgical technologies frequently operate within the broader reimbursement economics of the surgical episode rather than benefiting from a separate premium simply because a robotic or navigation system is used. Hospitals therefore assess whether the technology improves measurable economics through shorter length of stay, greater minimally invasive utilization, reduced complications, higher operating-room throughput, increased surgeon recruitment, stronger regional referrals, implant standardization or greater utilization of profitable surgical service lines.

The market also exhibits unusually strong recurring-revenue characteristics. Capital systems create installed bases that generate demand for procedure-specific instruments, disposables, service agreements, software subscriptions, system upgrades, imaging accessories and clinical training. This makes utilization more strategically important than unit placements alone. Manufacturers capable of placing systems and subsequently increasing procedure volume can build durable recurring revenue while improving customer economics through greater asset utilization.

From 2026 through 2035, computer-assisted surgery will progressively become less identifiable as a separate technology category and more embedded in mainstream surgical infrastructure. High-value operating rooms will increasingly combine robotics, navigation, advanced visualization, intraoperative imaging, digital documentation and AI-supported analytics within a connected procedural environment.

 

Key Market Drivers: What’s Fueling the U.S. Computer-Assisted Surgical Systems Market Boom?

The first major driver is the continued expansion of robotic-assisted procedure volumes. In 2025, U.S. da Vinci procedure volume reached approximately 2.01 million cases, representing around 15% annual growth. General surgery alone accounted for approximately 1.25 million U.S. procedures, demonstrating how robotic surgery has expanded substantially beyond its earlier concentration in prostatectomy and gynecology. Cholecystectomy, hernia repair, appendectomy and colorectal procedures are becoming important contributors to incremental robotic utilization.

The installed-base expansion required to support this procedural demand is equally important. Approximately 987 da Vinci systems were placed in the United States during 2025, while the total U.S. installed base increased to more than 6,300 systems. A growing installed base creates additional procedure capacity and encourages health systems to develop standardized robotic training, credentialing, staffing and operating-room workflows. This infrastructure reduces adoption friction for additional indications and future generations of computer-assisted technologies.

The second driver is the economic importance of surgery within U.S. hospital strategy. Surgical service lines can generate substantial facility revenue and often support downstream imaging, pathology, rehabilitation and specialty-care utilization. Health systems therefore view advanced surgical technology not simply as an equipment purchase but as an instrument for physician recruitment, referral retention and service-line differentiation. In competitive metropolitan markets, access to contemporary robotic or navigation technology can materially influence surgeon affiliation decisions.

A third growth driver is the increasing clinical burden of diseases requiring technically demanding surgery. The aging U.S. population is expanding the eligible pool for joint replacement, spine procedures, cancer surgery and other complex interventions. Orthopedic robotics and navigation are particularly well positioned because knee and hip arthroplasty are high-volume, standardized procedures in which patient-specific planning, component positioning and alignment can be integrated directly with implant platforms. Stryker’s Mako technology had been used in more than 2.5 million procedures globally by 2025, illustrating the scale already reached by orthopedic robotic assistance.

The fourth driver is the migration of appropriate surgical procedures into outpatient settings. More than 6,300 Medicare-participating ASCs create a large potential secondary market for right-sized computer-assisted technology. Manufacturers are responding with modular robotic systems, compact orthopedic platforms and systems intended to require less dedicated infrastructure. The opportunity is significant because outpatient facilities usually place greater emphasis on turnover time, predictable procedure economics, smaller capital commitments and flexible room utilization.

A fifth driver is intensifying competition following new regulatory clearances. Historically, U.S. soft-tissue robotic surgery was highly concentrated. That environment is changing. CMR Surgical obtained U.S. authorization for the Versius platform beginning with cholecystectomy, Distalmotion expanded DEXTER indications, and Medtronic received FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures in December 2025. The introduction of additional platforms creates purchasing alternatives for hospitals and can accelerate system replacement, contracting innovation and robotic capacity expansion.

The sixth driver is the convergence of robotics with surgical navigation. Computer-assisted surgery is increasingly characterized by hybrid platforms combining image registration, navigation, robotics and intraoperative visualization. Spine surgery is a leading example. Technologies such as Globus Medical’s ExcelsiusGPS combine robotic trajectory guidance with navigation, while augmented-reality platforms can place navigation information directly within the surgeon’s field of view. These technologies address procedure accuracy and workflow rather than simply reproducing manual instrument movement.

The seventh driver is the growing value of surgical data. Computer-assisted platforms generate structured information on instrument movement, procedural steps, imaging, system utilization and workflow duration. Manufacturers are increasingly converting this data into training, performance analytics and AI-assisted decision-support tools. For hospital systems, the long-term strategic value may come from combining procedural technology with continuous measurement of surgical performance.

Finally, workforce economics are becoming increasingly important. U.S. health systems face shortages and uneven geographic availability of experienced surgeons, nurses and operating-room personnel. Computer-assisted platforms cannot eliminate these constraints, but technologies that standardize planning, improve visualization, simplify complex tasks or shorten training requirements can improve the productivity of constrained clinical teams. Procurement decisions through 2035 will increasingly evaluate this workforce impact alongside traditional clinical outcomes.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation is shifting from first-generation robotization toward intelligent surgical assistance. The next generation of systems increasingly combines mechanical precision with sensing, visualization, software and computational support. Rather than simply allowing a surgeon to operate remotely from a console, future differentiation will depend on how effectively technology helps clinicians understand anatomy, plan the procedure, recognize risk and execute standardized surgical steps.

Force-feedback technology represents one area of development. Conventional robotic systems historically relied heavily on visual interpretation rather than direct tactile feedback. Newer system generations are incorporating force-sensing capabilities designed to provide additional information about tissue interaction. As these capabilities mature, they could improve instrument control and reduce dependence on indirect visual cues.

Artificial intelligence and computer vision represent another major innovation frontier. Surgical platforms can increasingly analyze video streams, identify procedural phases, detect instrument position and structure postoperative case data. These capabilities are creating a pathway toward real-time surgical decision support. The commercial opportunity extends beyond the robot itself because hospitals may ultimately pay for software that converts procedural data into workflow optimization, training and quality metrics.

Modularity is also becoming strategically important. Rather than requiring a permanently configured operating room, newer soft-tissue robots increasingly use independent or mobile robotic arms. Modular architecture allows health systems to configure the operating room according to procedure type and may improve utilization across multiple specialties. This design philosophy is particularly relevant for community hospitals and ASCs where room flexibility is economically essential.

Orthopedic and spine systems are moving toward deeper integration of planning, navigation and execution. Contemporary knee robotics use patient-specific planning and real-time tracking to guide bone preparation and component alignment. Spine systems increasingly combine preoperative CT, intraoperative imaging, tracked instruments and robotic trajectory guidance. The value proposition increasingly revolves around reproducibility and workflow integration rather than robotics as a stand-alone feature.

Augmented and mixed reality are creating another computer-assisted interface. FDA-cleared systems already allow navigational data or virtual anatomical information to be projected into a surgeon’s field of view. This could reduce the need to repeatedly look away from the operative field toward conventional navigation monitors. Continued improvements in headset ergonomics, registration and visualization are likely to increase adoption in spine, neurosurgery and complex orthopedic procedures.

Automation will progress cautiously but meaningfully. Fully autonomous surgery remains outside the mainstream commercial market, but specific subtasks can increasingly be constrained, guided or partially automated. Examples include robotic positioning, automated depth stops, trajectory alignment, tissue recognition and procedural workflow detection. Manufacturers are likely to pursue incremental autonomy because narrowly defined functions can be validated more realistically than end-to-end autonomous surgery.

Business-model innovation is equally important. Large upfront capital purchases can restrict adoption, particularly among lower-volume hospitals. Leasing, usage-based arrangements, bundled instruments, procedure-based payments and subscription software can redistribute capital expenditure into operating expense. These models also align manufacturer economics more closely with procedure growth. Over the forecast period, financing architecture may become almost as important as mechanical performance in winning competitive hospital accounts.

 

Segmentation Insights

The U.S. Computer-Assisted Surgical Systems Market is segmented on the basis of product category, surgical specialty/application, end user, technology type and region.

 

By Product Category

Robotic Surgical Systems and Associated Instruments

Robotic surgical platforms represent the largest product category and are estimated to account for more than half of market value in 2025. This category includes soft-tissue robotic systems, orthopedic robots, robotic spine systems, endovascular robots and procedure-linked instruments and accessories. Recurring instrument consumption makes this category economically larger than capital placements alone. Growth will be driven by procedure expansion, competitive system launches and broader availability outside major tertiary hospitals.

Surgical Navigation Systems

Surgical navigation systems form a major computer-assisted category across orthopedic, spine, neurosurgical and ENT applications. Optical, electromagnetic and imaging-based navigation systems help identify anatomy and track instrument position relative to preoperative or intraoperative images. Navigation is becoming increasingly integrated with robotic guidance and intraoperative imaging, reducing the distinction between conventional navigation systems and newer robotic platforms.

Surgical Planning and Simulation Systems

Computer-assisted planning platforms use CT, MRI, fluoroscopy or other imaging inputs to define patient-specific anatomy and procedural objectives before surgical execution. Orthopedic implant positioning, cranial targeting, spine trajectories and complex reconstructive surgery increasingly depend on digital planning. The segment is moving toward cloud-based collaboration and algorithm-assisted planning rather than stand-alone workstation software.

Intraoperative Visualization and Guidance Systems

Advanced visualization includes 3D image fusion, augmented reality, mixed reality, tracked displays and imaging interfaces that improve surgeon orientation during procedures. The segment is particularly important in spine, neuro, orthopedic, ENT and image-guided interventions. Demand is supported by the need to maintain minimally invasive approaches even as procedural complexity increases.

Software, Analytics and Platform Services

Software and service revenue represents the fastest-evolving component of the market. Surgical video analytics, remote case support, procedural data management, system utilization analytics, predictive maintenance and AI-enabled workflow applications are becoming differentiators. While smaller than hardware and instruments in 2025, software-related revenue is expected to capture a rising share of incremental value through 2035.

 

By Surgical Specialty/Application

General and Abdominal Surgery

General surgery is the largest soft-tissue computer-assisted application. U.S. da Vinci general surgery volume reached approximately 1.25 million procedures in 2025, with particularly strong activity in cholecystectomy, inguinal and ventral hernia repair, colorectal surgery and appendectomy. High procedural frequency creates strong utilization economics for hospitals, making general surgery critical to robotic system return on investment.

Orthopedic and Spine Surgery

Orthopedic and spine applications represent one of the largest and most strategically attractive computer-assisted markets. Robotic knee and hip replacement platforms integrate planning, tracking and implant-specific workflows, while spine systems use navigation and robotic guidance for trajectories and implant placement. The category benefits from aging demographics, large procedure volumes and direct integration between computer-assisted platforms and manufacturers’ implant franchises.

Urologic Surgery

Urology remains one of the most deeply penetrated robotic specialties. Approximately 201,000 U.S. da Vinci urology procedures were performed in 2025, and robotic assistance is already used in a large majority of several major abdominal urologic surgeries. Prostatectomy, partial nephrectomy, nephrectomy and cystectomy remain important procedures. Medtronic’s U.S. Hugo clearance is also initially focused on urologic indications, making the specialty a key competitive battleground.

Gynecologic Surgery

Gynecology accounted for approximately 468,000 U.S. da Vinci procedures in 2025. Robotic hysterectomy, sacrocolpopexy and selected gynecologic oncology procedures form an established utilization base. The segment is also strategically attractive for newer modular robotic platforms because many gynecologic procedures have the potential to transition into shorter-stay or outpatient environments when patient selection permits.

Neurosurgery, ENT, Cardiothoracic and Other Applications

This combined segment contains some of the most technology-intensive computer-assisted workflows. Cranial navigation, stereotactic guidance, spine-related neurosurgery, transoral procedures, thoracic surgery and selected cardiac applications depend heavily on visualization, navigation or robotic assistance. Procedure volumes may be lower than general surgery, but capital intensity and technical requirements can support high revenue per case.

 

By End User

General Hospitals and Integrated Health Systems

General acute-care hospitals and integrated delivery networks constitute the dominant end-user category. Their purchasing decisions increasingly occur at the enterprise level, allowing health systems to standardize robotic, navigation and imaging platforms across multiple hospitals. Large systems focus heavily on total ownership cost, instrument economics, uptime, cybersecurity, clinical training and multi-specialty utilization.

Academic and Tertiary Medical Centers

Academic medical centers remain disproportionately important to innovation adoption. They participate in clinical trials, evaluate new system generations, train surgeons and establish procedural protocols that influence broader community adoption. Emerging robotic platforms frequently target major academic centers during early commercialization because sophisticated surgical teams can evaluate performance across complex procedures.

Ambulatory Surgery Centers

ASCs represent the fastest-growing site-of-care opportunity. The United States has more than 6,300 Medicare-participating ASCs, creating substantial potential for technologies that fit outpatient economics. Compact orthopedic robots, modular soft-tissue systems and lower-infrastructure navigation platforms are particularly relevant. Winning this segment requires lower capital intensity, rapid room setup, predictable disposable costs and high procedure throughput.

Specialty Orthopedic, Spine and Surgical Hospitals

Specialty surgical facilities can generate unusually high utilization for orthopedic robotics, spine navigation and other procedure-specific technologies. Because their case mix is concentrated, these facilities can justify technology purchases through standardized workflows and implant volume. Integrated implant-robotics contracting can be especially influential within this segment.

Federal, Veterans and Other Surgical Facilities

Federal and Veterans Health Administration facilities represent a smaller but strategically relevant market. Procurement cycles can be slower and purchasing structures differ from commercial health systems, but large regional centers perform complex orthopedic, oncology, urologic and general surgery procedures. Service support, long equipment life and standardized training are particularly important purchasing considerations.

 

By Technology Type

Robotic-Assisted Surgery

Robotic assistance remains the largest technology type. Systems range from multi-port soft-tissue robots to single-port platforms, modular robots, orthopedic robotic arms, spine robots and endovascular systems. Competition will increasingly focus on procedure breadth, setup time, ergonomics, reusable versus disposable economics, system footprint and integration with existing surgical portfolios.

Optical Navigation

Optical tracking systems use cameras and tracked markers to determine instrument and anatomical position. They are well established in orthopedic, spine and neurosurgical workflows. Continued innovation is focused on registration speed, line-of-sight management, accuracy and integration with robotic platforms and intraoperative imaging.

Electromagnetic and Image-Based Navigation

Electromagnetic systems allow instrument tracking without the same direct line-of-sight requirements as optical systems, while image-based guidance combines preoperative or intraoperative datasets with real-time procedural localization. These systems are relevant in ENT, neuro, spine and other anatomically constrained procedures.

AI-Enabled Planning and Computer Vision

Artificial intelligence is emerging as the fastest-growing digital layer. Applications include automatic anatomical segmentation, patient-specific surgical planning, procedural video analysis, workflow recognition and performance analytics. During the forecast period, AI is expected to migrate from retrospective analysis toward increasingly real-time assistance, although clinical validation and regulatory requirements will constrain the pace of automation.

Augmented Reality, Mixed Reality and Advanced Visualization

AR and mixed-reality technologies overlay digital guidance on the operative environment. FDA activity in orthopedic augmented reality and mixed-reality navigation has increased, supporting broader commercialization. Spine surgery is currently one of the strongest use cases, but applications are expected to broaden as visualization hardware becomes lighter, more ergonomic and more integrated with conventional navigation.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Computer-Assisted Surgical Systems Market is geographically segmented into the South, West, Northeast and Midwest. Regional opportunity depends on population size, surgical procedure volumes, hospital consolidation, academic medical-center density, surgeon availability, aging demographics, payer mix, outpatient infrastructure and willingness to invest in high-cost capital equipment.

The South is estimated to represent the largest regional market in 2025 at approximately USD 3.45 billion, followed by the Northeast at around USD 2.72 billion, the West at approximately USD 2.71 billion and the Midwest at nearly USD 1.96 billion. The West is expected to record the fastest growth through 2035, while the South should remain the largest absolute revenue opportunity.

South

The South represents approximately 31.8% of the U.S. market in 2025 and is expected to reach around USD 12.55 billion by 2035. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Tennessee, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma and West Virginia. Large and expanding population centers, significant surgical demand and extensive health-system development support adoption.

Texas is one of the most strategically important computer-assisted surgery markets in the country. Its estimated 2025 population exceeds 31.7 million, making it the second-largest state by population. Houston, Dallas-Fort Worth, Austin and San Antonio contain large academic institutions, integrated health systems and specialty surgery networks. Texas is also becoming an important commercialization location for emerging robotic platforms, with early U.S. clinical and commercial activity involving newer soft-tissue systems occurring in the state.

Florida represents another major opportunity because its 2025 population exceeds 23.4 million and includes a particularly large older-adult population. Orthopedic replacement, spine surgery, urology, cancer surgery and general surgery therefore represent substantial addressable procedure pools. Florida’s extensive ambulatory surgery infrastructure also creates favorable conditions for compact robotic and computer-assisted orthopedic technologies.

North Carolina, Georgia, Tennessee and Virginia represent attractive expansion markets because of rapid population growth, major tertiary referral centers and expanding health-system networks. North Carolina in particular combines research-intensive academic medicine with fast-growing metropolitan regions. Georgia benefits from Atlanta’s large clinical market, while Tennessee combines nationally recognized healthcare organizations with regional surgical referral activity.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma and West Virginia present a different commercial opportunity. Their advanced surgical capacity is often concentrated in major urban referral centers, while rural populations face greater access constraints. Technologies that can improve surgical standardization, remote collaboration or regional referral efficiency may therefore have particular relevance.

By 2035, the South should remain the largest regional revenue pool because it combines population expansion, high surgical demand, rapidly developing metropolitan healthcare infrastructure and strong outpatient growth. Manufacturers able to establish enterprise contracts with large multistate health systems will have an important competitive advantage.

West

The West accounted for approximately USD 2.71 billion in 2025 and is projected to approach USD 10.47 billion by 2035, representing the fastest regional CAGR at approximately 14.5%. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii.

California is the largest individual state opportunity in the West and remains the most populous U.S. state at approximately 39.36 million residents in 2025. Its healthcare market includes internationally recognized academic medical centers, extensive integrated delivery networks, high surgical volumes and a dense medical-device and digital-health ecosystem. California is especially important for the commercialization of orthopedic robotics, surgical AI, navigation, AR, interventional robotics and software-supported surgery.

The state’s technology ecosystem also makes it an important development location. Several robotics, digital surgery and computer-assisted technology companies have operations or origins in California. Provider systems in the state are generally sophisticated evaluators of digital infrastructure, creating opportunities for platforms capable of demonstrating interoperability with imaging systems, electronic health records and procedural-data environments.

Arizona and Nevada represent high-growth markets because of migration, expanding metropolitan populations and large retirement communities. Arizona’s 2025 population exceeded 7.6 million, creating growing demand for orthopedic, spine, urologic and general surgical procedures. Phoenix in particular is developing into a major regional healthcare hub.

Washington and Oregon have strong integrated health systems and relatively high acceptance of digitally enabled care, supporting adoption of advanced navigation and connected surgical workflow systems. Colorado and Utah combine growing populations with established regional referral hospitals and orthopedic capacity. Smaller western states such as Idaho and Montana are likely to favor technologies that can support centralized specialist networks and improve procedural standardization across dispersed populations.

The West is expected to outperform the national CAGR because the region combines population expansion in several states, technology-intensive health systems and a strong innovation ecosystem. AI-enabled surgery, augmented reality, advanced spine navigation and new robotic architectures should gain especially strong traction.

Northeast

The Northeast accounted for approximately USD 2.72 billion in 2025 and is expected to reach nearly USD 9.39 billion by 2035. The region includes New York, Massachusetts, Pennsylvania, New Jersey, Connecticut, Maine, Vermont, New Hampshire, Rhode Island and Delaware. Although population growth is slower than in the South and parts of the West, surgical complexity and premium technology adoption remain exceptionally high.

New York is the largest state market in the region, with a 2025 population of approximately 20.0 million. New York City contains one of the country’s highest concentrations of major academic hospitals and specialist surgical programs. Robotic surgery, complex oncology, neurosurgery, spine surgery and transplant-related care support demand for sophisticated computer-assisted platforms.

Pennsylvania, with more than 13.0 million residents, offers a large mix of academic, integrated and community hospital systems. Philadelphia and Pittsburgh provide major technology-adoption hubs. New Jersey is also attractive because of its high population density, substantial hospital infrastructure and proximity to major New York and Philadelphia healthcare markets.

Massachusetts has a smaller population of roughly 7.15 million but carries disproportionate strategic importance due to its concentration of academic medicine, biotechnology, clinical research and medical-device innovation. Hospitals in Boston frequently serve as evaluation centers for emerging surgical technologies and can influence surgeon training and downstream adoption.

Connecticut, Rhode Island, New Hampshire, Maine, Vermont and Delaware form smaller state markets, but several benefit from strong regional referral relationships with major academic systems. Aging demographics in northern New England support orthopedic and surgical demand, although smaller hospital footprints can limit adoption of the highest-cost platforms.

The Northeast should grow somewhat more slowly than the West because of market maturity and population trends. Nevertheless, its concentration of complex procedures and teaching institutions makes it one of the highest-value regions for new product introduction, clinical evidence generation and premium system adoption.

Midwest

The Midwest represented approximately USD 1.96 billion in 2025 and is expected to reach about USD 6.45 billion by 2035. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota and South Dakota.

Illinois is the region’s largest state market, with approximately 12.72 million residents in 2025. Chicago’s academic hospitals, health systems and specialty surgical facilities support significant robotic, orthopedic, spine and image-guided procedure activity. The state also functions as an important clinical launch market because of the concentration of tertiary centers.

Ohio, with approximately 11.9 million residents, has one of the country’s strongest tertiary-care infrastructures and has become particularly visible in next-generation surgical robotics. Cleveland and other metropolitan areas provide substantial procedure volumes across urology, cardiovascular surgery, orthopedics, oncology and general surgery.

Michigan provides a large established surgical market supported by major integrated provider networks and academic medicine. Minnesota is strategically significant because of its longstanding medical-device ecosystem and sophisticated health systems. These states are important markets for both capital platforms and software-integrated surgical technologies.

Indiana, Wisconsin and Missouri provide stable demand across orthopedic replacement, spine, general surgery and urology. Iowa, Kansas, Nebraska, North Dakota and South Dakota have smaller population bases and greater rural dispersion, which favors technologies capable of supporting regional centers with standardized workflows and reliable remote service.

The Midwest is expected to record the slowest of the four regional growth rates, at approximately 12.6% through 2035, but should remain a highly dependable market. Strong integrated health systems, mature orthopedic service lines and significant clinical expertise create a stable foundation for replacement cycles and next-generation technology upgrades.

 

Key Market Players

The U.S. Computer-Assisted Surgical Systems competitive landscape is shifting from a highly concentrated structure toward a broader ecosystem of established medtech companies and specialized technology developers. Intuitive Surgical remains the benchmark competitor in soft-tissue robotic surgery because of its large installed base, extensive procedure portfolio, surgeon familiarity and recurring instruments-and-accessories model. However, competition is strengthening in both soft-tissue and orthopedic robotics.

Some of the key companies relevant to the U.S. market include Intuitive Surgical, Medtronic, Stryker, Zimmer Biomet, Johnson & Johnson MedTech, Smith+Nephew, Globus Medical, Brainlab, Siemens Healthineers, GE HealthCare, CMR Surgical, Distalmotion, THINK Surgical, PROCEPT BioRobotics, Augmedics, Microbot Medical, Stereotaxis, Renishaw, KARL STORZ, Moon Surgical, Vicarious Surgical, OrthAlign, Medacta, Accuray and eCential Robotics.

Intuitive Surgical has the strongest established ecosystem in multi-specialty soft-tissue robotic surgery. The company’s U.S. installed base exceeded 6,300 da Vinci systems at year-end 2025, while more than two million U.S. da Vinci procedures were completed during the year. Its competitive advantages include procedure breadth, surgeon training infrastructure, recurring instrument revenue, installed-base familiarity and a rapidly expanding next-generation da Vinci 5 platform.

Medtronic represents one of the most significant emerging challengers following U.S. clearance of the Hugo robotic-assisted surgery system for urology. Its strategic advantage extends beyond the robot itself because Medtronic can integrate robotics with established surgical energy, instrumentation and digital-surgery assets. Expansion into general and gynecologic surgery would materially increase its addressable U.S. market.

Stryker and Zimmer Biomet are major competitors in orthopedic robotics, where platform economics are closely linked to implant share. Stryker’s Mako franchise has reached more than 2.5 million global procedures and supports knee and hip workflows. Zimmer Biomet continues expanding ROSA technologies and intelligent surgical planning. Smith+Nephew and THINK Surgical add further competition in robotic-assisted orthopedic procedures.

Globus Medical, Brainlab and Augmedics are particularly important in navigation-intensive spine and neurosurgical applications. Competition in this market increasingly depends on imaging compatibility, registration, implant integration, augmented reality, workflow efficiency and ability to combine robotics with navigation.

Emerging players are broadening the definition of computer-assisted surgery. PROCEPT BioRobotics applies robotic planning and execution to urologic tissue removal; Microbot Medical is developing a single-use remotely operated endovascular robotic model; Stereotaxis focuses on robotic magnetic navigation; and newer soft-tissue platforms are challenging assumptions about system footprint, modularity and outpatient economics.

Over the forecast period, market share will increasingly be determined by the ability to create an ecosystem rather than a single device. Companies capable of combining capital equipment, instruments, software, data analytics, clinical evidence, training, financing and service will have a structural advantage in health-system negotiations.

 

Recent Developments

The competitive environment changed materially in late 2025 and 2026 with the arrival of additional U.S. soft-tissue robotic alternatives. In December 2025, Medtronic received FDA clearance for the Hugo robotic-assisted surgery system for minimally invasive urologic procedures, including prostatectomy, nephrectomy and cystectomy. The first U.S. commercial Hugo procedure was subsequently performed in February 2026, providing a meaningful new competitive alternative in a robotic category historically dominated by Intuitive.

Medtronic continued its expansion strategy in June 2026 by submitting filings intended to expand Hugo into general surgery and gynecologic applications in the United States. Expansion into these specialties would be strategically important because general surgery represents the largest incremental soft-tissue robotic procedure pool.

CMR Surgical has also strengthened its U.S. position. The Versius Surgical System initially received U.S. De Novo marketing authorization for adult cholecystectomy, and the newer Versius Plus subsequently received FDA clearance. Its modular architecture illustrates the industry’s broader move toward systems designed for operating-room flexibility and potentially wider site-of-care adoption.

Johnson & Johnson MedTech advanced the OTTAVA program in April 2025 with completion of the system’s first clinical study cases in the United States, beginning with gastric bypass procedures in Texas. Commercial entry by Johnson & Johnson would materially affect competition because the company already controls a large conventional surgery portfolio and extensive U.S. hospital relationships.

Orthopedic robotics also continued to evolve. Zimmer Biomet received FDA clearance in November 2025 for an enhanced ROSA Knee configuration incorporating more personalized intelligent surgical planning and tracking features. THINK Surgical received additional FDA clearances for its TMINI miniature robotic platform, reinforcing industry movement toward smaller-footprint systems.

Augmented reality and navigation innovation accelerated during the same period. FDA clearances during 2025 included further updates to Augmedics’ xvision spine technology and mixed-reality navigation capabilities from other developers. These approvals demonstrate that computer-assisted surgery is developing through multiple interface models rather than robotics alone.

Endovascular robotics emerged as another important frontier when Microbot Medical received FDA 510(k) clearance in September 2025 for the LIBERTY Endovascular Robotic System, which targets a large U.S. peripheral endovascular procedure opportunity. This development illustrates how computer-assisted technology is moving into interventional procedural environments traditionally outside conventional operating-room robotics.

PROCEPT BioRobotics also continued advancing robotic urology, including additional FDA clearance activity involving its HYDROS robotic system during 2026. The company’s model demonstrates how computer-assisted technologies can gain adoption by solving a highly specific procedural need rather than competing as a multi-specialty surgical robot.

Collectively, these developments suggest that the U.S. market is moving from a predominantly single-platform era toward a multi-platform environment involving differentiated robotic architectures, procedure-specific robots, intelligent navigation, augmented reality and AI-supported surgical workflows.

 

Conclusion

The U.S. Computer-Assisted Surgical Systems Market Size & Share is positioned to expand from approximately USD 10.84 billion in 2025 to USD 38.86 billion by 2035, representing a 13.62% CAGR during 2026–2035. Historical market value increased from approximately USD 5.95 billion in 2021 to USD 9.39 billion in 2024 as robotic surgery, orthopedic navigation, spine guidance and digital surgical technologies moved into wider clinical use.

The fundamental growth driver is not simply increasing automation. The market is expanding because computer assistance is becoming increasingly capable of solving tangible surgical workflow problems: improving visualization, standardizing planning, guiding instrument trajectories, integrating imaging, enabling minimally invasive procedures, improving implant positioning and generating actionable procedural data.

Soft-tissue robotics will remain the largest revenue pool, but incremental growth will diversify. Orthopedic robotics, robotic spine navigation, compact robotic platforms, augmented reality, endovascular robotics, AI-assisted surgical analytics and procedure-specific systems will capture a larger share of investment through 2035.

The competitive environment will become materially less concentrated. Intuitive Surgical will continue to benefit from one of the strongest installed bases and procedural ecosystems in medical devices, but Medtronic, CMR Surgical, Johnson & Johnson MedTech, Distalmotion and other emerging competitors are expanding the range of U.S. robotic alternatives. Orthopedic and navigation markets will remain contested by Stryker, Zimmer Biomet, Smith+Nephew, Globus Medical, Brainlab, THINK Surgical and other specialists.

Regional opportunity will remain concentrated in large procedure markets. The South is expected to remain the largest region, supported by Texas, Florida, North Carolina and Georgia. The West should record the fastest growth, led by California, Arizona and other technology-intensive states. The Northeast will remain critical for complex surgery and early technology evaluation, while the Midwest will provide a stable base of orthopedic, spine and advanced hospital demand.

For manufacturers, investors and healthcare providers evaluating this market, the critical strategic question is no longer whether computer-assisted surgery will expand. The more important issue is which technologies can produce sufficient clinical and economic value to justify their place within increasingly constrained surgical budgets.

Hospital buyers will increasingly demand evidence around system utilization, procedure time, staffing requirements, consumable cost, conversion to minimally invasive surgery, complication economics, room turnover, service reliability and capital efficiency. A technically sophisticated platform without a defensible workflow and economic proposition will face substantial adoption resistance.

The companies best positioned through 2035 will therefore be those capable of combining clinical precision with procedure economics. Robotics, navigation, artificial intelligence and visualization will increasingly function as interconnected elements of a digital surgical ecosystem rather than independent technology categories. The long-term U.S. opportunity will be defined by platforms that help hospitals perform more appropriate procedures, with greater consistency, using constrained clinical resources while generating evidence that supports both patient outcomes and health-system economics.

 

TABLE OF CONTENT

1. U.S. Computer-Assisted Surgical Systems Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Robotic and Computer-Assisted Surgical System Manufacturers
1.6.2. Surgical Navigation, Imaging and Software Developers
1.6.3. Components, Sensors, Instruments and Contract Manufacturing Suppliers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Academic Medical Centers and Specialty Surgical Hospitals
1.6.6. Ambulatory Surgery Centers
1.6.7. Group Purchasing Organizations and Distribution Partners
1.6.8. Surgeons, Clinical Decision-Makers, Payers and Regulators

What this section provides: This section establishes the definition and boundaries of the U.S. computer-assisted surgical systems market, explains the research and forecasting methodology, and maps the manufacturers, technology providers, healthcare facilities, procurement stakeholders and regulatory participants influencing market development.

2. U.S. Computer-Assisted Surgical Systems Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, 2021–2035 (US$ Billion)
2.8. High-Growth Opportunity Areas
2.9. Robotic-Assisted Procedure Adoption Snapshot
2.10. Installed Base and Procedure Utilization Outlook

What this section provides: This section gives decision-makers a concise view of market size, historical performance, 2025 positioning, forecast growth, system utilization, technology adoption and the most attractive commercial opportunities through 2035.

3. U.S. Computer-Assisted Surgical Systems Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Adoption of Robotic-Assisted Surgical Procedures
3.1.2. Expansion of Minimally Invasive Surgery Across Major Specialties
3.1.3. Growth of Orthopedic and Spine Robotic Navigation
3.1.4. Hospital Operating Room Digitization and Modernization
3.1.5. Rising Surgical Procedure Volumes Among the Aging U.S. Population
3.1.6. Increasing Demand for Surgical Precision and Workflow Standardization
3.1.7. Expansion of Computer-Assisted Surgery Into Community Hospitals and ASCs
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Acquisition and Installation Costs
3.2.2. Recurring Instrument, Accessory and Maintenance Expenses
3.2.3. Limited Direct Reimbursement Premium for Robotic Technology
3.2.4. Surgeon Training and Learning-Curve Requirements
3.2.5. Operating Room Utilization and Capital ROI Constraints
3.3. Opportunities and Their Impact Analysis
3.3.1. Modular and Compact Robotic Surgical Systems
3.3.2. Artificial Intelligence and Computer Vision in Surgery
3.3.3. Augmented Reality and Mixed-Reality Surgical Navigation
3.3.4. Procedure-Specific Robotic Platforms
3.3.5. Outpatient and Ambulatory Robotic Surgery
3.3.6. Usage-Based and Procedure-Based Commercial Models
3.3.7. Enterprise-Level Digital Surgery Platforms
3.4. Challenges and Their Impact Analysis
3.4.1. Demonstrating Clinical and Economic Superiority
3.4.2. System Interoperability and Operating Room Integration
3.4.3. Cybersecurity and Connected Surgical Platform Risks
3.4.4. Competitive Pricing Pressure
3.4.5. Surgical Workforce and Technical Support Constraints
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Robotic Procedure Economics and Utilization Analysis
3.8. Hospital Capital Procurement Behavior Analysis
3.9. Installed Base Replacement and Upgrade Cycle Analysis
3.10. Surgeon Training and Credentialing Landscape

What this section provides: This section analyzes the clinical, financial, workflow and technology forces influencing computer-assisted surgical system adoption and helps clients evaluate market-growth drivers, adoption barriers, procurement risks and emerging commercial opportunities.

4. U.S. Computer-Assisted Surgical Systems Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digital Surgery and Connected Operating Rooms
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Surgical Payment Landscape
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Healthcare Technology Programs
4.11. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.13. Cybersecurity and Software Lifecycle Requirements
4.14. Operating Room Interoperability and Data Integration Landscape

What this section provides: This section provides an integrated view of regulation, reimbursement, pricing, technology infrastructure, supply chains, cybersecurity, hospital procurement criteria and external factors affecting the commercial environment for computer-assisted surgical systems.

5. U.S. Computer-Assisted Surgical Systems Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Robotic Surgical Systems and Associated Instruments
5.1.2.1. Soft-Tissue Robotic Surgical Systems
5.1.2.2. Orthopedic Robotic Surgical Systems
5.1.2.3. Spine and Neurosurgical Robotic Systems
5.1.2.4. Procedure-Specific Robotic Systems
5.1.2.5. Instruments, Accessories and Procedure Consumables
5.1.3. Surgical Navigation Systems
5.1.3.1. Orthopedic Navigation Systems
5.1.3.2. Spine Navigation Systems
5.1.3.3. Neurosurgical Navigation Systems
5.1.3.4. ENT and Craniofacial Navigation Systems
5.1.4. Surgical Planning and Simulation Systems
5.1.4.1. Preoperative Planning Platforms
5.1.4.2. Patient-Specific Surgical Planning
5.1.4.3. Surgical Simulation and Training Platforms
5.1.5. Intraoperative Visualization and Guidance Systems
5.1.5.1. 3D Visualization Systems
5.1.5.2. Image-Guided Surgical Systems
5.1.5.3. Augmented and Mixed-Reality Guidance Systems
5.1.6. Software, Analytics and Platform Services
5.1.6.1. Surgical Workflow Software
5.1.6.2. Procedural Video Analytics
5.1.6.3. AI-Enabled Surgical Analytics
5.1.6.4. Remote Support and Digital Platform Services

What this section provides: This section identifies the computer-assisted surgical product categories expected to generate the strongest revenue contribution, recurring procedure economics and technology growth through 2035.

6. U.S. Computer-Assisted Surgical Systems Market – By Surgical Specialty/Application

6.1. Overview
6.1.1. Segment Share Analysis, By Surgical Specialty/Application, 2025 & 2035 (%)
6.1.2. General and Abdominal Surgery
6.1.2.1. Hernia Repair
6.1.2.2. Cholecystectomy
6.1.2.3. Colorectal Surgery
6.1.2.4. Bariatric Surgery
6.1.2.5. Other General Surgical Procedures
6.1.3. Orthopedic and Spine Surgery
6.1.3.1. Total Knee Arthroplasty
6.1.3.2. Total Hip Arthroplasty
6.1.3.3. Partial Knee Arthroplasty
6.1.3.4. Spine Fusion and Instrumentation
6.1.3.5. Other Orthopedic Procedures
6.1.4. Urologic Surgery
6.1.4.1. Prostatectomy
6.1.4.2. Partial and Radical Nephrectomy
6.1.4.3. Cystectomy
6.1.4.4. Benign Prostatic Hyperplasia Procedures
6.1.4.5. Other Urologic Procedures
6.1.5. Gynecologic Surgery
6.1.5.1. Hysterectomy
6.1.5.2. Sacrocolpopexy
6.1.5.3. Gynecologic Oncology
6.1.5.4. Other Gynecologic Procedures
6.1.6. Neurosurgery, ENT, Cardiothoracic and Other Applications
6.1.6.1. Cranial and Neurosurgical Procedures
6.1.6.2. ENT and Transoral Procedures
6.1.6.3. Thoracic Surgery
6.1.6.4. Cardiothoracic Surgery
6.1.6.5. Endovascular and Interventional Procedures
6.1.6.6. Other Computer-Assisted Surgical Applications

What this section provides: This section analyzes computer-assisted surgical demand by specialty and procedure type, helping clients identify high-volume applications, emerging robotic indications and surgical specialties with the strongest adoption potential.

7. U.S. Computer-Assisted Surgical Systems Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. General Hospitals and Integrated Health Systems
7.1.2.1. Large Integrated Delivery Networks
7.1.2.2. Community Hospitals
7.1.2.3. Regional Referral Hospitals
7.1.3. Academic and Tertiary Medical Centers
7.1.3.1. Academic Teaching Hospitals
7.1.3.2. Comprehensive Cancer Centers
7.1.3.3. Tertiary and Quaternary Surgical Centers
7.1.4. Ambulatory Surgery Centers
7.1.4.1. Multispecialty ASCs
7.1.4.2. Orthopedic ASCs
7.1.4.3. Spine Surgery Centers
7.1.4.4. Other Specialty ASCs
7.1.5. Specialty Orthopedic, Spine and Surgical Hospitals
7.1.5.1. Orthopedic Specialty Hospitals
7.1.5.2. Spine Specialty Centers
7.1.5.3. Specialty Surgical Hospitals
7.1.6. Federal, Veterans and Other Surgical Facilities
7.1.6.1. Veterans Health Administration Facilities
7.1.6.2. Military Medical Centers
7.1.6.3. Other Federal and Public Surgical Facilities

What this section provides: This section evaluates where computer-assisted surgical systems are installed and utilized and identifies the healthcare settings expected to generate the strongest capital-equipment demand, procedure utilization and recurring system revenue.

8. U.S. Computer-Assisted Surgical Systems Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Robotic-Assisted Surgery
8.1.2.1. Multi-Port Robotic Systems
8.1.2.2. Single-Port Robotic Systems
8.1.2.3. Modular Robotic Systems
8.1.2.4. Robotic-Arm Orthopedic Systems
8.1.2.5. Procedure-Specific Robotic Systems
8.1.3. Optical Navigation
8.1.3.1. Camera-Based Navigation
8.1.3.2. Marker-Based Tracking
8.1.3.3. Instrument Tracking Systems
8.1.4. Electromagnetic and Image-Based Navigation
8.1.4.1. Electromagnetic Tracking
8.1.4.2. CT-Based Navigation
8.1.4.3. Fluoroscopy-Based Navigation
8.1.4.4. Intraoperative Imaging Integration
8.1.5. AI-Enabled Planning and Computer Vision
8.1.5.1. AI-Based Anatomical Segmentation
8.1.5.2. Surgical Workflow Recognition
8.1.5.3. AI-Assisted Procedure Planning
8.1.5.4. Surgical Video Intelligence
8.1.6. Augmented Reality, Mixed Reality and Advanced Visualization
8.1.6.1. Augmented Reality Navigation
8.1.6.2. Mixed-Reality Surgical Guidance
8.1.6.3. 3D Visualization
8.1.6.4. Spatial Computing Interfaces

What this section provides: This section evaluates the technology platforms shaping next-generation computer-assisted surgery and compares robotic assistance, navigation, AI, computer vision, augmented reality and advanced surgical visualization.

9. U.S. Computer-Assisted Surgical Systems Market – By Procurement & Commercial Model

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement & Commercial Model, 2025 & 2035 (%)
9.1.2. Direct Capital Purchase
9.1.2.1. Hospital Capital Budget Purchase
9.1.2.2. Specialty Facility Capital Purchase
9.1.3. Leasing and Managed Equipment Agreements
9.1.3.1. Operating Lease Models
9.1.3.2. Managed Equipment Service Agreements
9.1.4. Procedure-Based and Pay-Per-Use Models
9.1.4.1. Procedure-Based Pricing
9.1.4.2. Usage-Based Contracts
9.1.4.3. Capital-to-Consumables Conversion Models
9.1.5. IDN, GPO and Enterprise Contracts
9.1.5.1. Integrated Delivery Network Contracts
9.1.5.2. Group Purchasing Organization Agreements
9.1.5.3. Multi-Hospital Enterprise Standardization
9.1.6. Software Subscription, Service and Upgrade Contracts
9.1.6.1. Annual Service Agreements
9.1.6.2. Software Subscription Models
9.1.6.3. System Upgrade Agreements
9.1.6.4. Data and Analytics Service Contracts

What this section provides: This section explains how U.S. hospitals, IDNs, specialty centers and ASCs acquire and finance computer-assisted surgical technologies and evaluates the growing importance of leasing, procedure-based contracting, subscriptions and enterprise agreements.

10. U.S. Computer-Assisted Surgical Systems Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Computer-Assisted Procedure Volume Analysis
10.1.4. Regional Hospital, ASC and Surgical Infrastructure Analysis
10.1.5. Regional Robotic Installed Base and Utilization Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics
10.1.7. Regional Technology Adoption and Capital Investment Trends
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Surgical Specialty/Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement & Commercial Model, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed four-region and 50-state market analysis, enabling clients to compare state-level computer-assisted surgery adoption, hospital and ASC infrastructure, installed-base potential, procedure intensity, technology investment and commercial opportunity.

11. U.S. Computer-Assisted Surgical Systems Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Competitive Analysis by Technology Platform
11.4.1. Soft-Tissue Robotic Surgery
11.4.2. Orthopedic Robotics
11.4.3. Spine and Neurosurgical Navigation
11.4.4. AI and Surgical Intelligence
11.4.5. Augmented Reality and Advanced Visualization
11.5. Company Profiles
11.5.1. Intuitive Surgical, Inc.
11.5.2. Medtronic plc
11.5.3. Stryker Corporation
11.5.4. Zimmer Biomet Holdings, Inc.
11.5.5. Johnson & Johnson MedTech
11.5.6. Smith+Nephew plc
11.5.7. Globus Medical, Inc.
11.5.8. Brainlab AG
11.5.9. Siemens Healthineers AG
11.5.10. GE HealthCare Technologies Inc.
11.5.11. CMR Surgical Ltd.
11.5.12. Distalmotion SA
11.5.13. THINK Surgical, Inc.
11.5.14. PROCEPT BioRobotics Corporation
11.5.15. Augmedics Ltd.
11.5.16. Microbot Medical Inc.
11.5.17. Stereotaxis, Inc.
11.5.18. Renishaw plc
11.5.19. KARL STORZ SE & Co. KG
11.5.20. Moon Surgical SAS
11.5.21. Vicarious Surgical Inc.
11.5.22. OrthAlign, Inc.
11.5.23. Medacta International SA
11.5.24. eCential Robotics
11.5.25. Noah Medical Corporation
11.6. Company Profile Parameters
11.6.1. Company Overview
11.6.2. Computer-Assisted Surgical Systems Portfolio
11.6.3. U.S. Market Presence and Commercial Strategy
11.6.4. Installed Base and Procedure Strategy
11.6.5. Financial and Business Positioning
11.6.6. FDA Regulatory and Clinical Pipeline
11.6.7. Partnerships, Acquisitions and Collaborations
11.6.8. Product Launches and Recent Developments
11.6.9. Strategic Strengths and Competitive Risks

What this section provides: This section provides competitor benchmarking, market-share visibility, technology-platform positioning and strategic intelligence on 25 leading and emerging companies competing in the U.S. computer-assisted surgical systems industry.

12. U.S. Computer-Assisted Surgical Systems Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Next-Generation Modular and Multi-Specialty Robotic Systems
12.2.2. Artificial Intelligence and Surgical Computer Vision
12.2.3. Augmented Reality, Mixed Reality and Spatial Computing
12.2.4. Semi-Autonomous and Task-Automated Surgical Robotics
12.2.5. Cloud-Connected Surgical Data and Analytics Platforms
12.3. Future of Soft-Tissue Robotic Surgery
12.4. Future of Orthopedic and Spine Robotics
12.5. Future of Computer-Assisted Surgery in ASCs
12.6. Emerging Business and Commercialization Trends
12.7. Potential Impact of Multi-Vendor Robotic Competition
12.8. Business Opportunities for Startups and Existing Players
12.9. Investment Prioritization Matrix
12.10. Technology Adoption Curve, 2026–2035

What this section provides: This section prepares clients for changes in surgical robotics, AI, navigation, automation and digital operating-room infrastructure and identifies technologies and business models likely to reshape market structure through 2035.

13. U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations

13.1. Recommendations for Robotic and Surgical System Manufacturers
13.2. Recommendations for Navigation and Surgical Software Companies
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Ambulatory Surgery Centers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. U.S. Go-to-Market Strategy Considerations
13.9. Hospital Capital Procurement Strategy
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Surgeon Training and Clinical Adoption Strategy
13.12. Recurring Revenue and Procedure Utilization Strategy
13.13. Partnership, Licensing and M&A Opportunity Framework

What this section provides: This section converts market intelligence into actionable recommendations for product strategy, hospital commercialization, surgeon adoption, investment prioritization, recurring revenue development and competitive expansion in the U.S. market.

14. U.S. Computer-Assisted Surgical Systems Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Estimation and Modeling Disclaimer

What this section provides: This section clarifies the report’s market-sizing boundaries, forecasting limitations, third-party data considerations, legal conditions and appropriate use of market estimates.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Computer-Assisted Surgical Systems Market: Market Definition and Scope
TABLE 3: U.S. Computer-Assisted Surgical Systems Market: Research Methodology Framework
TABLE 4: U.S. Computer-Assisted Surgical Systems Market: Key Assumptions
TABLE 5: U.S. Computer-Assisted Surgical Systems Market: Market Ecosystem Overview
TABLE 6: U.S. Computer-Assisted Surgical Systems Market: Stakeholder Analysis
TABLE 7: U.S. Computer-Assisted Surgical Systems Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Computer-Assisted Surgical Systems Market: Analyst Viewpoint Summary
TABLE 9: U.S. Computer-Assisted Surgical Systems Market: Market Attractiveness Index
TABLE 10: U.S. Computer-Assisted Surgical Systems Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Computer-Assisted Surgical Systems Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Computer-Assisted Surgical Systems Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Computer-Assisted Surgical Systems Market: Robotic-Assisted Procedure and Installed Base Snapshot, 2025
TABLE 14: U.S. Computer-Assisted Surgical Systems Market: Drivers; Impact Analysis
TABLE 15: U.S. Computer-Assisted Surgical Systems Market: Restraints; Impact Analysis
TABLE 16: U.S. Computer-Assisted Surgical Systems Market: Opportunities; Impact Analysis
TABLE 17: U.S. Computer-Assisted Surgical Systems Market: Challenges; Impact Analysis
TABLE 18: U.S. Computer-Assisted Surgical Systems Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Computer-Assisted Surgical Systems Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Computer-Assisted Surgical Systems Market: Robotic Procedure Economics and Utilization Matrix
TABLE 21: U.S. Computer-Assisted Surgical Systems Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Computer-Assisted Surgical Systems Market: Installed Base Replacement and Upgrade Cycle Analysis
TABLE 23: U.S. Computer-Assisted Surgical Systems Market: Surgeon Training and Credentialing Landscape
TABLE 24: U.S. Computer-Assisted Surgical Systems Market: PESTEL Analysis
TABLE 25: U.S. Computer-Assisted Surgical Systems Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Computer-Assisted Surgical Systems Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Computer-Assisted Surgical Systems Market: Value Chain Analysis
TABLE 28: U.S. Computer-Assisted Surgical Systems Market: Supply Chain Analysis
TABLE 29: U.S. Computer-Assisted Surgical Systems Market: Digital Surgery and Connected Operating Room Impact
TABLE 30: U.S. Computer-Assisted Surgical Systems Market: Application & Innovation Landscape
TABLE 31: U.S. Computer-Assisted Surgical Systems Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Computer-Assisted Surgical Systems Market: CMS Reimbursement and Surgical Payment Landscape
TABLE 33: U.S. Computer-Assisted Surgical Systems Market: Import/Export Restrictions & Tariff Impact
TABLE 34: U.S. Computer-Assisted Surgical Systems Market: Government Initiatives and Healthcare Technology Programs
TABLE 35: U.S. Computer-Assisted Surgical Systems Market: Impact of Escalating Geopolitical and Supply-Chain Tensions
TABLE 36: U.S. Computer-Assisted Surgical Systems Market: Hospital Value Analysis Committee Decision Framework
TABLE 37: U.S. Computer-Assisted Surgical Systems Market: Cybersecurity and Software Lifecycle Requirements
TABLE 38: U.S. Computer-Assisted Surgical Systems Market: Operating Room Interoperability and Data Integration Landscape
TABLE 39: U.S. Computer-Assisted Surgical Systems Market: Product Category Snapshot, 2025
TABLE 40: Segment Dashboard; Definition and Scope, by Product Category
TABLE 41: U.S. Computer-Assisted Surgical Systems Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 42: U.S. Computer-Assisted Surgical Systems Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 43: U.S. Computer-Assisted Surgical Systems Market: Robotic Surgical Systems and Associated Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Computer-Assisted Surgical Systems Market: Surgical Navigation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Computer-Assisted Surgical Systems Market: Surgical Planning and Simulation Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Computer-Assisted Surgical Systems Market: Intraoperative Visualization and Guidance Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Computer-Assisted Surgical Systems Market: Software, Analytics and Platform Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Computer-Assisted Surgical Systems Market: Surgical Specialty/Application Snapshot, 2025
TABLE 49: Segment Dashboard; Definition and Scope, by Surgical Specialty/Application
TABLE 50: U.S. Computer-Assisted Surgical Systems Market, by Surgical Specialty/Application, 2021–2035 (US$ Billion)
TABLE 51: U.S. Computer-Assisted Surgical Systems Market: Segment Share Analysis, by Surgical Specialty/Application, 2025 & 2035 (%)
TABLE 52: U.S. Computer-Assisted Surgical Systems Market: General and Abdominal Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Computer-Assisted Surgical Systems Market: Orthopedic and Spine Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Computer-Assisted Surgical Systems Market: Urologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Computer-Assisted Surgical Systems Market: Gynecologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Computer-Assisted Surgical Systems Market: Neurosurgery, ENT, Cardiothoracic and Other Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Computer-Assisted Surgical Systems Market: End User Snapshot, 2025
TABLE 58: Segment Dashboard; Definition and Scope, by End User
TABLE 59: U.S. Computer-Assisted Surgical Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 60: U.S. Computer-Assisted Surgical Systems Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 61: U.S. Computer-Assisted Surgical Systems Market: General Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Computer-Assisted Surgical Systems Market: Academic and Tertiary Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Computer-Assisted Surgical Systems Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Computer-Assisted Surgical Systems Market: Specialty Orthopedic, Spine and Surgical Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Computer-Assisted Surgical Systems Market: Federal, Veterans and Other Surgical Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Computer-Assisted Surgical Systems Market: Technology Type Snapshot, 2025
TABLE 67: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 68: U.S. Computer-Assisted Surgical Systems Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 69: U.S. Computer-Assisted Surgical Systems Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 70: U.S. Computer-Assisted Surgical Systems Market: Robotic-Assisted Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Computer-Assisted Surgical Systems Market: Optical Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Computer-Assisted Surgical Systems Market: Electromagnetic and Image-Based Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Computer-Assisted Surgical Systems Market: AI-Enabled Planning and Computer Vision Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Computer-Assisted Surgical Systems Market: Augmented Reality, Mixed Reality and Advanced Visualization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Computer-Assisted Surgical Systems Market: Procurement & Commercial Model Snapshot, 2025
TABLE 76: Segment Dashboard; Definition and Scope, by Procurement & Commercial Model
TABLE 77: U.S. Computer-Assisted Surgical Systems Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 78: U.S. Computer-Assisted Surgical Systems Market: Segment Share Analysis, by Procurement & Commercial Model, 2025 & 2035 (%)
TABLE 79: U.S. Computer-Assisted Surgical Systems Market: Direct Capital Purchase Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Computer-Assisted Surgical Systems Market: Leasing and Managed Equipment Agreements Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Computer-Assisted Surgical Systems Market: Procedure-Based and Pay-Per-Use Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Computer-Assisted Surgical Systems Market: IDN, GPO and Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Computer-Assisted Surgical Systems Market: Software Subscription, Service and Upgrade Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Computer-Assisted Surgical Systems Market: Regional Snapshot, 2025
TABLE 85: Segment Dashboard; Definition and Scope, by Region
TABLE 86: U.S. Computer-Assisted Surgical Systems Market, by Region, 2021–2035 (US$ Billion)
TABLE 87: U.S. Computer-Assisted Surgical Systems Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 88: U.S. Computer-Assisted Surgical Systems Market: Regional Procedure Volume and Installed Base Analysis, 2025
TABLE 89: West Region U.S. Computer-Assisted Surgical Systems Market: Regional Overview and Trends
TABLE 90: West Region U.S. Computer-Assisted Surgical Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 91: West Region U.S. Computer-Assisted Surgical Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Computer-Assisted Surgical Systems Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Computer-Assisted Surgical Systems Market, by Surgical Specialty/Application, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Computer-Assisted Surgical Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Computer-Assisted Surgical Systems Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Computer-Assisted Surgical Systems Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 97: California Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 98: Washington Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 99: Arizona Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 100: Colorado Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 101: Oregon Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 102: Utah Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 103: Nevada Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 104: New Mexico Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 105: Idaho Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 106: Montana Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 107: Wyoming Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 108: Alaska Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 109: Hawaii Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 110: Northeast Region U.S. Computer-Assisted Surgical Systems Market: Regional Overview and Trends
TABLE 111: Northeast Region U.S. Computer-Assisted Surgical Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 112: Northeast Region U.S. Computer-Assisted Surgical Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 113: Northeast Region U.S. Computer-Assisted Surgical Systems Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Computer-Assisted Surgical Systems Market, by Surgical Specialty/Application, 2021–2035 (US$ Billion)
TABLE 115: Northeast Region U.S. Computer-Assisted Surgical Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 116: Northeast Region U.S. Computer-Assisted Surgical Systems Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 117: Northeast Region U.S. Computer-Assisted Surgical Systems Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 118: New York Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 119: Massachusetts Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 120: New Jersey Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 121: Pennsylvania Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 122: Connecticut Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 123: Maine Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 124: Vermont Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 125: New Hampshire Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 126: Rhode Island Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 127: Delaware Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Computer-Assisted Surgical Systems Market: Regional Overview and Trends
TABLE 129: South Region U.S. Computer-Assisted Surgical Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 130: South Region U.S. Computer-Assisted Surgical Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 131: South Region U.S. Computer-Assisted Surgical Systems Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 132: South Region U.S. Computer-Assisted Surgical Systems Market, by Surgical Specialty/Application, 2021–2035 (US$ Billion)
TABLE 133: South Region U.S. Computer-Assisted Surgical Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 134: South Region U.S. Computer-Assisted Surgical Systems Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 135: South Region U.S. Computer-Assisted Surgical Systems Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 136: Texas Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 137: Florida Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 138: Georgia Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 139: North Carolina Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 140: Tennessee Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 141: South Carolina Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 142: Alabama Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 143: Mississippi Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 144: Louisiana Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 145: Arkansas Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 146: Kentucky Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 147: Oklahoma Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 148: Virginia Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 149: Maryland Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 150: West Virginia Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Computer-Assisted Surgical Systems Market: Regional Overview and Trends
TABLE 152: Midwest Region U.S. Computer-Assisted Surgical Systems Market: Key Manufacturers and Procurement Ecosystem
TABLE 153: Midwest Region U.S. Computer-Assisted Surgical Systems Market, by State, 2021–2035 (US$ Billion)
TABLE 154: Midwest Region U.S. Computer-Assisted Surgical Systems Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 155: Midwest Region U.S. Computer-Assisted Surgical Systems Market, by Surgical Specialty/Application, 2021–2035 (US$ Billion)
TABLE 156: Midwest Region U.S. Computer-Assisted Surgical Systems Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Midwest Region U.S. Computer-Assisted Surgical Systems Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 158: Midwest Region U.S. Computer-Assisted Surgical Systems Market, by Procurement & Commercial Model, 2021–2035 (US$ Billion)
TABLE 159: Illinois Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 160: Ohio Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 161: Michigan Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 162: Minnesota Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 163: Indiana Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 164: Wisconsin Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 165: Missouri Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 166: Iowa Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 167: Kansas Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 168: Nebraska Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 169: North Dakota Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 170: South Dakota Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
TABLE 171: U.S. Computer-Assisted Surgical Systems Market: Competitive Landscape Snapshot, 2025
TABLE 172: U.S. Computer-Assisted Surgical Systems Market: Key Company Market Share Analysis, 2025
TABLE 173: U.S. Computer-Assisted Surgical Systems Market: Company Positioning Matrix
TABLE 174: U.S. Computer-Assisted Surgical Systems Market: Technology Platform Benchmarking of Key Players
TABLE 175: U.S. Computer-Assisted Surgical Systems Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 176: Intuitive Surgical, Inc.: Company Profile
TABLE 177: Medtronic plc: Company Profile
TABLE 178: Stryker Corporation: Company Profile
TABLE 179: Zimmer Biomet Holdings, Inc.: Company Profile
TABLE 180: Johnson & Johnson MedTech: Company Profile
TABLE 181: Smith+Nephew plc: Company Profile
TABLE 182: Globus Medical, Inc.: Company Profile
TABLE 183: Brainlab AG: Company Profile
TABLE 184: Siemens Healthineers AG: Company Profile
TABLE 185: GE HealthCare Technologies Inc.: Company Profile
TABLE 186: CMR Surgical Ltd.: Company Profile
TABLE 187: Distalmotion SA: Company Profile
TABLE 188: THINK Surgical, Inc.: Company Profile
TABLE 189: PROCEPT BioRobotics Corporation: Company Profile
TABLE 190: Augmedics Ltd.: Company Profile
TABLE 191: Microbot Medical Inc.: Company Profile
TABLE 192: Stereotaxis, Inc.: Company Profile
TABLE 193: Renishaw plc: Company Profile
TABLE 194: KARL STORZ SE & Co. KG: Company Profile
TABLE 195: Moon Surgical SAS: Company Profile
TABLE 196: Vicarious Surgical Inc.: Company Profile
TABLE 197: OrthAlign, Inc.: Company Profile
TABLE 198: Medacta International SA: Company Profile
TABLE 199: eCential Robotics: Company Profile
TABLE 200: Noah Medical Corporation: Company Profile
TABLE 201: U.S. Computer-Assisted Surgical Systems Market: Future Market Scenario Analysis, 2026–2035
TABLE 202: U.S. Computer-Assisted Surgical Systems Market: Disruptive Technologies Impact Matrix
TABLE 203: U.S. Computer-Assisted Surgical Systems Market: Future of Soft-Tissue Robotic Surgery
TABLE 204: U.S. Computer-Assisted Surgical Systems Market: Future of Orthopedic and Spine Robotics
TABLE 205: U.S. Computer-Assisted Surgical Systems Market: ASC Adoption Opportunity, 2026–2035
TABLE 206: U.S. Computer-Assisted Surgical Systems Market: Multi-Vendor Robotic Competition Outlook
TABLE 207: U.S. Computer-Assisted Surgical Systems Market: Emerging Business Trends
TABLE 208: U.S. Computer-Assisted Surgical Systems Market: Business Opportunities for Startups and Existing Players
TABLE 209: U.S. Computer-Assisted Surgical Systems Market: Investment Prioritization Matrix
TABLE 210: U.S. Computer-Assisted Surgical Systems Market: Technology Adoption Curve, 2026–2035
TABLE 211: U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations for Robotic and Surgical System Manufacturers
TABLE 212: U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations for Navigation and Surgical Software Companies
TABLE 213: U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 214: U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 215: U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 216: U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 217: U.S. Computer-Assisted Surgical Systems Market: Strategic Recommendations for New Entrants and Startups
TABLE 218: U.S. Computer-Assisted Surgical Systems Market: U.S. Go-to-Market Strategy Considerations
TABLE 219: U.S. Computer-Assisted Surgical Systems Market: Hospital Capital Procurement Strategy
TABLE 220: U.S. Computer-Assisted Surgical Systems Market: Product Positioning and Portfolio Expansion Guidance
TABLE 221: U.S. Computer-Assisted Surgical Systems Market: Surgeon Training and Clinical Adoption Strategy
TABLE 222: U.S. Computer-Assisted Surgical Systems Market: Recurring Revenue and Procedure Utilization Strategy
TABLE 223: U.S. Computer-Assisted Surgical Systems Market: Partnership, Licensing and M&A Opportunity Framework
TABLE 224: U.S. Computer-Assisted Surgical Systems Market: Scope Limitation
TABLE 225: U.S. Computer-Assisted Surgical Systems Market: Data Use Limitation
TABLE 226: U.S. Computer-Assisted Surgical Systems Market: Forecasting Limitation
TABLE 227: U.S. Computer-Assisted Surgical Systems Market: Legal Disclaimer
TABLE 228: U.S. Computer-Assisted Surgical Systems Market: Third-Party Data Disclaimer
TABLE 229: U.S. Computer-Assisted Surgical Systems Market: Market Estimation and Modeling Disclaimer

List of Figures

FIGURE 1: U.S. Computer-Assisted Surgical Systems Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Robotic Procedure Economics and Utilization Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: Installed Base Replacement and Upgrade Cycle
FIGURE 14: Surgeon Training and Credentialing Landscape
FIGURE 15: U.S. Computer-Assisted Surgical Systems Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Computer-Assisted Surgical Systems Market Year-wise Growth Curve, 2021–2035
FIGURE 18: U.S. Robotic-Assisted Surgical Procedure and Installed Base Trend, 2021–2035
FIGURE 19: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 20: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Robotic Surgical Systems and Associated Instruments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Surgical Navigation Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Surgical Planning and Simulation Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Intraoperative Visualization and Guidance Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Software, Analytics and Platform Services Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Surgical Specialty/Application Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Surgical Specialty/Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: General and Abdominal Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Orthopedic and Spine Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Urologic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Gynecologic Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Neurosurgery, ENT, Cardiothoracic and Other Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 34: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: General Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Academic and Tertiary Medical Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Specialty Orthopedic, Spine and Surgical Hospitals Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Federal, Veterans and Other Surgical Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Robotic-Assisted Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Optical Navigation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Electromagnetic and Image-Based Navigation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: AI-Enabled Planning and Computer Vision Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Augmented Reality, Mixed Reality and Advanced Visualization Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Procurement & Commercial Model Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Procurement & Commercial Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Direct Capital Purchase Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Leasing and Managed Equipment Agreements Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Procedure-Based and Pay-Per-Use Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: IDN, GPO and Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Software Subscription, Service and Upgrade Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Computer-Assisted Surgical Systems Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. Computer-Assisted Surgical Systems Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Delaware Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: South Region U.S. Computer-Assisted Surgical Systems Market Share and Leading Players, 2025
FIGURE 86: South Region Market Share Analysis by State, 2025
FIGURE 87: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Texas Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Florida Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Georgia Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: North Carolina Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Tennessee Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: South Carolina Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Alabama Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Mississippi Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Louisiana Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Arkansas Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Kentucky Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Oklahoma Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Virginia Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Maryland Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: West Virginia Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Midwest Region U.S. Computer-Assisted Surgical Systems Market Share and Leading Players, 2025
FIGURE 104: Midwest Region Market Share Analysis by State, 2025
FIGURE 105: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Illinois Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Ohio Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Michigan Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Minnesota Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Indiana Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Wisconsin Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Missouri Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Iowa Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Kansas Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Nebraska Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: North Dakota Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: South Dakota Computer-Assisted Surgical Systems Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 119: Company Positioning Matrix
FIGURE 120: Key Player Technology Platform Benchmarking
FIGURE 121: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 122: Computer-Assisted Surgery Innovation Roadmap
FIGURE 123: Soft-Tissue Robotic Surgery Competition Roadmap
FIGURE 124: Orthopedic and Spine Robotics Opportunity Map
FIGURE 125: AI, Computer Vision and Surgical Intelligence Roadmap
FIGURE 126: Augmented Reality and Advanced Visualization Adoption Roadmap
FIGURE 127: Future Market Scenario Analysis, 2026–2035
FIGURE 128: Disruptive Technologies Impact Matrix
FIGURE 129: ASC Computer-Assisted Surgery Adoption Roadmap
FIGURE 130: Multi-Vendor Robotic Competition Outlook
FIGURE 131: Emerging Business Trends Matrix
FIGURE 132: Technology Adoption Curve, 2026–2035
FIGURE 133: Investment Prioritization Matrix
FIGURE 134: Strategic Growth Roadmap for U.S. Computer-Assisted Surgical Systems Companies
FIGURE 135: U.S. Go-to-Market Strategy Framework
FIGURE 136: Hospital Capital Procurement Strategy Framework
FIGURE 137: Product Positioning and Portfolio Expansion Framework
FIGURE 138: Surgeon Training and Clinical Adoption Framework
FIGURE 139: Recurring Revenue and Procedure Utilization Framework
FIGURE 140: Partnership, Licensing and M&A Opportunity Framework
FIGURE 141: Report Scope and Disclaimer Framework